MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Assessment of Gait in Huntington’s disease patients using EncephaLog smartphone’s application

NI. Inbar, N. Omer, A. Bar David, N. Geva, I. Dabakarov, L. Barsky, Z. Yekutieli, N. Giladi, T. Gurevich (Tel Aviv, Israel)

Meeting: 2019 International Congress

Abstract Number: 21

Keywords: Gait disorders: Clinical features

Session Information

Date: Monday, September 23, 2019

Session Title: Huntington’s Disease

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Huntington’s disease (HD) patients cope with unique gait disturbances. Proper evaluation of gait in these patients is highly needed. Dyskinesia may negatively affect validity of gait assessments. Quantitative gait evaluation can currently be performed only in dedicated gait labs. This is a feasibility study aimed to assess an HD gait-analysis App using a standard smartphone, accessible for every physician and patient.

Background: Huntington’s disease (HD) patients cope with unique gait disturbances.

Method: Participants’ gait was evaluated using EncephaLog App, using a smartphone’s integral accelerometers and gyroscope for capturing the subject’s trajectory. For each subject, three Timed up-and-go test (TUG) sessions were recorded. Raw data was sent to a server where several gait biomarkers were extracted. Patients were also evaluated clinically ̶ physical, cognitive and functional data was collected.

Results: 25 genetically confirmed HD patients (13 females) participated: Mean age: 52.3±13.79; CAG length:44.5±5.182; Disease duration: 6.7 years±4.12;UHDRS total score:38.25±14.48; UHDRS dyskinesia score:1.02 ±1.14;UHDRS gait score:1.04±0.55; Total functional capacity: 5.68±3.132; Mean MoCA score:18.6±4.55. There were substantial correlations between different gait parameters measured by EncephaLog system, for example: Stand-up time and Sit-down time (r=0.58, p=0.003), Rotation time and step length (r=0.61, p=0.0016), Medio-lateral sway and steps frequency (r=0.55, p=0.0048). Such correlations were kept for patients with high UHDRS dyskinesia scores. Correlation were found between EncephaLog outputs and Gait UHDRS scores (rotation time: r=0.72, p=0.0001; sit-down time: r=0.52, p=0.011; Medio-lateral sway: r=0.45, p=0.032).

Conclusion: EncephaLog system was able to assess gait parameters in HD with acceptable accuracy. Participants cooperated well with the smartphone assessment, despite cognitive problems. Although chorea ̶ a common symptom in HD ̶ challenges biomarker-extraction from raw data, we found that using a combination of several motion-capturing sensors was helpful for identifying key events in the TUG sequence. Further studies will be performed to validate the precision of quantitative gait analysis by EncephaLog App.

To cite this abstract in AMA style:

NI. Inbar, N. Omer, A. Bar David, N. Geva, I. Dabakarov, L. Barsky, Z. Yekutieli, N. Giladi, T. Gurevich. Assessment of Gait in Huntington’s disease patients using EncephaLog smartphone’s application [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/assessment-of-gait-in-huntingtons-disease-patients-using-encephalog-smartphones-application/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/assessment-of-gait-in-huntingtons-disease-patients-using-encephalog-smartphones-application/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley